OpGen, Inc. (OTC:OPGN – Get Free Report) shares passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.73 and traded as high as $5.03. OpGen shares last traded at $4.95, with a volume of 2,624 shares trading hands.
OpGen Price Performance
The firm’s 50 day moving average price is $0.73 and its 200-day moving average price is $3.05. The firm has a market cap of $49.85 million, a price-to-earnings ratio of -0.89 and a beta of -1.77.
OpGen Company Profile
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Recommended Stories
- Five stocks we like better than OpGen
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
- Find and Profitably Trade Stocks at 52-Week Lows
- Amazon Is One of the Clearest Buys If the Market Dips Again
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
